FehrARPerlmanS.Coronaviruses: An overview of their replication and pathogenesis. Methods Mol Biol2015;
1282: 1–23.
2.
ChanJFKokKHZhuZ, et al.
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect2020;
9: 221–236.
3.
SalataCCalistriAParolinC, et al.
Antiviral activity of cationic amphiphilic drugs. Expert Rev Anti Infect Ther2017;
15: 483–492.
4.
SalataCBaritussioAMunegatoD, et al.
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process. Pathog Dis2015;
73: ftv032.
5.
StadlerKHaHRCiminaleV, et al.
Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level. Am J Respir Cell Mol Biol2008;
39: 142–149.
6.
ChengYLLanKHLeeWP, et al.
Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle. Clin Sci2013;
125: 439–448.
7.
WolfTKannGBeckerS, et al.
Severe Ebola virus disease with vascular leakage and multiorgan failure: Treatment of a patient in intensive care. Lancet2015;
385: 1428–1435.
8.
MendozaEJQiuXKobingerGP.Progression of Ebola therapeutics during the 2014–2015 outbreak. Trends Mol Med2016;
22: 164–173.
9.
GehringGRohrmannKAtenchongN, et al.
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. J Antimicrob Chemother2014;
69: 2123–2131.
10.
WangMCaoRZhangL, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. Epub ahead of print 4 February 2020. DOI: 10.1038/s41422-020-0282-0.
11.
DeWaldLEDyallJSwordJM, et al.
The calcium channel blocker bepridil demonstrates efficacy in the murine model of Marburg virus disease. J Infect Dis2018;
218: S588–S591.
12.
ChuCMChengVCHungIF, et al.
Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax2004;
59: 252–256.
